{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:44:37Z","timestamp":1788799477677,"version":"build-2803163510"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>Brentuximab vedotin is a conjugate drug used mainly in Hodgkin lymphoma, systemic and primary cutaneous anaplastic large cell lymphomas, and CD30-expressing peripheral T-cell lymphoma. We report a unique case of acute pancreatitis associated with brentuximab vedotin in a 17-year-old male patient suffering from classical Hodgkin lymphoma. Diagnosed in 2020, the patient was classified to an intermediate therapeutic group and disease\u2019s grade was IIIAE. The patient was treated with brentuximab vedotin and bendamustine in the third line. Two weeks after the drug administration, the patient developed acute epigastric pain. Laboratory and radiological findings confirmed the clinical suspicion of acute pancreatitis that was managed with opioid pain medications, meropenem, parenteral nutrition, ondansetron and omeprazole. This is the first case report of brentuximab vedotin-associated acute pancreatitis in the pediatric patient reported in the literature to the best of our knowledge.<\/jats:p>","DOI":"10.3389\/pore.2022.1610445","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T16:13:13Z","timestamp":1660320793000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Case Report: Brentuximab Vedotin Associated Acute Pancreatitis in a Pediatric Hodgkin Lymphoma Patient: Case Report and Literature Review"],"prefix":"10.3389","volume":"28","author":[{"given":"Ewelina","family":"Truszkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Andrzejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyntia","family":"Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Wzi\u0105tek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Derwich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3322\/caac.21637","article-title":"Cancer Statistics for Adolescents and Young Adults, 2020","volume":"443","author":"Miller","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1097\/HS9.0000000000000329","article-title":"Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group","volume":"4","author":"Daw","year":"2020","journal-title":"HemaSphere"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1200\/JCO.2003.07.124","article-title":"Prognostic Factors for Children with Hodgkin's Disease Treated with Combined-Modality Therapy","volume":"21","author":"Smith","year":"2003","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e26278","DOI":"10.1002\/pbc.2627810.1002\/pbc.26278","article-title":"Childhood Hodgkin International Prognostic Score (CHIPS) Predicts Event-free Survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group","volume":"64","author":"Schwartz","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1007\/s00247-018-4197-6","article-title":"Significance of Pleural Effusion at Diagnosis in Pediatric Hodgkin Lymphoma: A Report from Children's Oncology Group Protocol AHOD0031","volume":"48","author":"McCarten","year":"2018","journal-title":"Pediatr Radiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1182\/blood-2018-02-834465","article-title":"Pericardial Effusion in Hodgkin Lymphoma: A Report from the Children\u2019s Oncology Group AHOD0031 Protocol","volume":"132","author":"Marks","year":"2018","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after Two Cycles of Chemotherapy Predicts Treatment Failure and Progression-free Survival in Hodgkin Lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical Trials in Children","volume":"79","author":"Joseph","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cncr.31755","article-title":"Brentuximab Vedotin for Recurrent Hodgkin Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation: A Report from the EBMT Lymphoma Working Party","volume":"125","author":"Bazarbachi","year":"2019","journal-title":"Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"257e137","DOI":"10.1016\/S1470-2045(17)30912-9","article-title":"Brentuximab Vedotin Plus Bendamustine in Relapsed or Refractory Hodgkin's Lymphoma: an International, Multicentre, Single-Arm, Phase 1-2 trialErratum in","volume":"1919","author":"O'Connor","year":"2018","journal-title":"Lancet Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S1470-2045(18)30426-1","article-title":"Brentuximab Vedotin with Gemcitabine for Paediatric and Young Adult Patients with Relapsed or Refractory Hodgkin's Lymphoma (AHOD1221): A Children's Oncology Group, Multicentre Single-Arm, Phase 1\u20132 Trial","volume":"19","author":"Cole","year":"2018","journal-title":"Lancet Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/S2352-3026(18)30153-4","article-title":"Brentuximab Vedotin for Paediatric Relapsed or Refractory Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma: a Multicentre, Open-Label, Phase 1\/2 Study","volume":"5","author":"Locatelli","year":"2018","journal-title":"Lancet Haematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e5138","DOI":"10.7759\/cureus.5138","article-title":"Hypertriglyceridemia Induced Pancreatitis Due to Brentuximab Therapy: First Case Report","volume":"11","author":"Maradana","year":"2019","journal-title":"Cureus"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40268-014-0036-x","article-title":"Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report","volume":"14","author":"Urru","year":"2014","journal-title":"Drugs R D"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1182\/blood-2014-03-561878","article-title":"Pancreatitis in Patients Treated with Brentuximab Vedotin: A Previously Unrecognized Serious Adverse Event","volume":"123","author":"Gandhi","year":"2014","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V130.Suppl_1.4090.4090","article-title":"Brentuximab Vedotin in Combination with Bendamustine in Relapsed or Refractory Hodgkin Lymphoma: A Retrospective Analysis on 23 Paediatric Patients or Young Adults","volume":"130","author":"Vinti","year":"2017","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1111\/bjh.17274","article-title":"The Addition of Bendamustine to Brentuximab Vedotin Leads to Improved Rates of Complete Metabolic Remission in Children, Adolescents and Young Adults with Relapsed and Refractory Classical Hodgkin Lymphoma: A Retrospective Single-centre Series","volume":"192","author":"McMillan","year":"2021","journal-title":"Br J Haematol"},{"key":"B18","volume-title":"Euro-net-Paediatric Hodgkin\u2019s Lymphoma Group (Euro-Net-PHL-C2): Second International Inter-group Study for Classical Hodgkin Lymphoma in Children and Adolescents","author":"K\u00f6rholz","year":"2015"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/jcph.1682","article-title":"Population Pharmacokinetics of Brentuximab Vedotin in Adult and Pediatric Patients with Relapsed\/Refractory Hematologic Malignancies: Model-Informed Hypothesis Generation for Pediatric Dosing Regimens","volume":"60","author":"Suri","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1002618","DOI":"10.1371\/journal.pmed.1002618","article-title":"Metabolic and Lifestyle Risk Factors for Acute Pancreatitis in Chinese Adults: A Prospective Cohort Study of 0.5 Million People","volume":"15","author":"Pang","year":"2018","journal-title":"Plos Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s10620-020-06275-6","article-title":"High Body Mass Index and Central Adiposity Is Associated with Increased Risk of Acute Pancreatitis: A Meta-Analysis","volume":"66","author":"Aune","year":"2021","journal-title":"Dig Dis Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2645926","DOI":"10.1155\/2019\/2645926","article-title":"Relationships between Metabolic Comorbidities and Occurrence, Severity, and Outcomes in Patients with Acute Pancreatitis: A Narrative Review","volume":"2019","author":"Li","year":"2019","journal-title":"Biomed Res Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000327688","article-title":"Overweight Is an Additional Prognostic Factor in Acute Pancreatitis: A Meta-Analysis","volume":"11","author":"Wang","year":"2011","journal-title":"Pancreatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1200\/JCO.2018.79.0139","article-title":"Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients with Untreated Classical Hodgkin Lymphoma","volume":"36","author":"Evens","year":"2018","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jcrpr.2016.09.002","article-title":"Fatal Pancreatitis Occurred in a Patient with Refractory CD30+ Anaplastic Large Cell Lymphoma after Brentuximab Vedotin Treatment","volume":"4","author":"Ching Chen","year":"2017","journal-title":"J Cancer Res Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e10299","DOI":"10.7759\/cureus.10299","article-title":"Acute Pancreatitis Induced by Polatuzumab-Vedotin-Piiq in Combination with Bendamustine and Rituximab for Diffuse Large B-Cell Lymphoma","volume":"12","author":"Anderson","year":"2020","journal-title":"Cureus"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1053\/j.gastro.2013.01.069","article-title":"Genetic Risk Factors for Pancreatic Disorders","volume":"144","author":"Whitcomb","year":"2013","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s10620-010-1367-2","article-title":"Drug-Induced Acute Pancreatitis: Underdiagnosis and Overdiagnosis","volume":"55","author":"Tenner","year":"2010","journal-title":"Dig Dis Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/cam4.649","article-title":"Acute Pancreatitis as a Complication of Childhood Cancer Treatment.","volume":"5","author":"Stefanovi\u0107","year":"2016","journal-title":"Cancer Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/bjh.12016","article-title":"Asparaginase-associated Pancreatitis in Children","volume":"159","author":"Raja","year":"2012","journal-title":"Br J Haematol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3109\/10428194.2015.1101098","article-title":"Asparaginase-associated Toxicity in Children with Acute Lymphoblastic Leukemia","volume":"57","author":"Hijiya","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/leu.2011.84","article-title":"Dexamethasone versus Prednisone for Induction Therapy in Childhood Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis","volume":"25","author":"Teuffel","year":"2011","journal-title":"Leukemia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/pbc.22076","article-title":"Clinical Course and Outcome in Children with Acute Lymphoblastic Leukemia and Asparaginase-Associated Pancreatitis","volume":"53","author":"Kearney","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.17235\/reed.2020.7120\/2020","article-title":"Bortezomib-induced Acute Pancreatitis, an Uncommon Adverse Event","volume":"113","author":"Junquera Alonso","year":"2021","journal-title":"Rev Esp Enferm Dig"},{"key":"B35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.htct.2018.03.003","article-title":"Management of Pancreatitis Related to Bortezomib Treatment: Report of Two Cases","volume":"40","author":"Brulc","year":"2018","journal-title":"Hematol Transfus Cel Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/mph.0b013e318271c92f","article-title":"6-Mercaptopurine-induced Recurrent Acute Pancreatitis in Children with Acute Lymphoblastic Leukemia\/Lymphoma","volume":"35","author":"Halalsheh","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/pbc.25841","article-title":"Maintenance Treatment with Low-Dose Mercaptopurine in Combination with Allopurinol in Children with Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis","volume":"63","author":"Zerra","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1023\/a:1008342320532","article-title":"Pancreatitis during Therapy of Acute Myeloid Leukemia: Cytarabine Related?","volume":"10","author":"McGrail","year":"1999","journal-title":"Ann Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.bmt.1704429","article-title":"Acute Pancreatitis Due to Tacrolimus in a Case of Allogeneic Bone Marrow Transplantation","volume":"33","author":"Sastry","year":"2004","journal-title":"Bone Marrow Transpl"},{"key":"B40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12882-019-1395-x","article-title":"A Case Report: Acute Pancreatitis Associated with Tacrolimus in Kidney Transplantation","volume":"20","author":"Xu","year":"2019","journal-title":"BMC Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.3109\/10428194.2011.596963","article-title":"Prevention and Management of Asparaginase\/pegasparaginase-Associated Toxicities in Adults and Older Adolescents: Recommendations of an Expert Panel","volume":"52","author":"Stock","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"B42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MPG.0000000000001715","article-title":"Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report From the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee","volume":"66","author":"Abu-El-Haija","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1053\/j.gastro.2003.12.050","article-title":"Prophylactic Antibiotic Treatment in Patients with Predicted Severe Acute Pancreatitis: A Placebo-Controlled, Double-Blind Trial","volume":"126","author":"Isenmann","year":"2004","journal-title":"Gastroenterology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s11605-008-0773-7","article-title":"A Double-Blind, Placebo-Controlled Trial of Ciprofloxacin Prophylaxis in Patients with Acute Necrotizing Pancreatitis","volume":"13","author":"Garc\u00eda-Barrasa","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/medicina43040036","article-title":"Meta-analysis of Prophylactic Parenteral Antibiotic Use in Acute Necrotizing Pancreatitis","volume":"43","author":"Dambrauskas","year":"2007","journal-title":"Medicina (Kaunas)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"E248","DOI":"10.1188\/17.CJON.E248-E259","article-title":"Asparaginase Toxicities: Identification and Management in Patients with Acute Lymphoblastic Leukemia","volume":"21","author":"Thu Huynh","year":"2017","journal-title":"Clin J Oncol Nurs"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e000858","DOI":"10.1136\/esmoopen-2020-000858","article-title":"Managing Toxicities with Asparaginase Based Therapies in Adult ALL: Summary of an ESMO Open\u2013 Cancer Horizons Roundtable Discussion","volume":"5","author":"Burke","year":"2020","journal-title":"ESMO Open"},{"key":"B48","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/14740338.2016.1179277","article-title":"A Safety Evaluation of Brentuximab Vedotin for the Treatment of Hodgkin Lymphoma","volume":"15","author":"Oak","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1002\/cncr.28712","article-title":"Progressive Multifocal Leukoencephalopathy Associated with Brentuximab Vedotin Therapy: A Report of 5 Cases from the Southern Network on Adverse Reactions (SONAR) Project","volume":"120","author":"Carson","year":"2014","journal-title":"Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML Diagnostic Criteria: Consensus Statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"B51","volume-title":"Adcetris","year":"2022"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2022.1610445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T16:13:21Z","timestamp":1660320801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2022.1610445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":51,"alternative-id":["10.3389\/pore.2022.1610445"],"URL":"https:\/\/doi.org\/10.3389\/pore.2022.1610445","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"article-number":"1610445"}}